2021
DOI: 10.1080/17469899.2021.1999808
|View full text |Cite|
|
Sign up to set email alerts
|

Clinical improvement of ocular surface parameters in dry eye patients following treatment with urea/crosslinked-hyaluronate eyedrops correlates with the secretion of MUC-4

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…More recently, we also explored the possibility of using ornithine as a cross-linking agent in view of its biological properties, obtaining increased resistance to enzymatic degradation and conferring interesting biological properties against lung inflammation [ 41 ]. In addition, we recently hypothesized, for the first time, that cross-linked hyaluronic acid could be used in a collyrium preparation, which could be useful in treating eye-dryness syndromes [ 42 , 43 ].…”
Section: Introductionmentioning
confidence: 99%
“…More recently, we also explored the possibility of using ornithine as a cross-linking agent in view of its biological properties, obtaining increased resistance to enzymatic degradation and conferring interesting biological properties against lung inflammation [ 41 ]. In addition, we recently hypothesized, for the first time, that cross-linked hyaluronic acid could be used in a collyrium preparation, which could be useful in treating eye-dryness syndromes [ 42 , 43 ].…”
Section: Introductionmentioning
confidence: 99%